Updates to Medical Policies and Clinical UM Guidelines Effective January 15, 2012
|
|
- Alice Watson
- 5 years ago
- Views:
Transcription
1 Updates t Medical Plicies and Clinical UM Guidelines Effective January 15, 2012 UniCare is pleased t prvide yu with ur updated and new medical plicies and clinical UM guidelines. The majr new new plicies and changes are summarized belw. Additinal changes are included in Attachment A at the end f this dcument. Please refer t the specific plicy fr cding, language, and ratinale updates and changes that are nt summarized in this ntice. New Medical Plicies Effective January 15, 2012 DME Electric Tumr Treatment Field (TTF): This plicy addresses electrical fields knwn as tumr treatment fields (TTF), which are created by lw intensity, alternating intermediate frequency electric currents delivered t the malignant tumr site by insulated electrdes placed n skin surface f the tumr site. As a result f the unique shape and electrical characteristics f dividing tumr cells, TTF expsure may damage the dividing cells thrugh anti micrtubule mechanisms and culd stp tumr grwth while sparing nrmal tissue. The use f devices t generate electric tumr treating fields (TTF) as a treatment fr malignant tumrs is cnsidered investigatinal and nt medically necessary RAD Digital Breast Tmsynthesis: This plicy addresses digital breast tmsynthesis (DBT) (three dimensinal [3 D] mammgraphy), which is being investigated as an adjunct and alternative t x ray mammgraphy fr the screening and diagnsis f breast cancer. DBT cmbines the use f tmgraphy and 3 D recnstructin with breast imaging t imprve the visibility f breast lesins. Digital breast tmsynthesis is cnsidered investigatinal and nt medically necessary fr all indicatins SURG Sacral Nerve Stimulatin (SNS) and Percutaneus Tibial Nerve Stimulatin (PTNS) fr Urinary and Fecal Incntinence; Urinary Retentin: This plicy addresses sacral nerve stimulatin (SNS) and percutaneus tibial nerve stimulatin (PTNS) in thse with chrnic, refractry urinary and fecal incntinence as well as urinary retentin. Outlines medically necessary, and investigatinal and nt medically necessary indicatins fr sacral nerve stimulatin (SNS) fr urinary incntinence and retentin, and fecal incntinence Lists investigatinal and nt medically necessary indicatins fr percutaneus tibial nerve stimulatin (PTNS) Mved infrmatin and criteria n sacral nerve stimulatin fr urinary indicatins and PTNS frm SURG t this new plicy Sacral nerve stimulatin and PTNS fr fecal incntinence nw addressed n this plicy SURG Radifrequency and Pulsed Radifrequency Ablatin f Trigger Pint Pain: This plicy addresses the treatment f trigger pint pain with radifrequency (RF) r pulsed radifrequency (PRF) ablatin. Radifrequency (RF) and pulsed radifrequency (PRF) ablatin treatment f trigger pints are cnsidered investigatinal and nt medically necessary Cverage and administrative services are prvided by UniCare Life & Health Insurance Cmpany, a separately incrprated and capitalized subsidiary f WellPint, Inc. Registered mark f WellPint, Inc WellPint, Inc.
2 SURG Ablatin f Sft Tissue Using Irreversible Electrpratin (IRE): This plicy addresses use f the Nanknife Oncbinic System fr sft tissue ablatin, which is classified by the U.S. Fd and Drug Administratin (FDA) as a Class II electrsurgical cutting and cagulatin device. Ablatin f sft tissue using irreversible electrpratin (IRE) is cnsidered investigatinal and nt medically necessary fr all indicatins Revised Medical Plicies and Adpted Clinical UM Guidelines Effective January 15, 2012 DRUG Belimumab (Benlysta ): This plicy addresses the use f belimumab fr the treatment f individuals age 18 r lder with active, antibdy psitive systemic lupus erythematsus (SLE), and fr ther indicatins. Remved SLE clinical manifestatins requirement and list frm medically necessary criteria Added psychsis and seizures as examples f active central nervus system lupus in medically necessary criteria Clarified sterid requirement in medically necessary criteria Remved "females wh are pregnant r nursing" as cntraindicatin Clarified investigatinal and nt medically necessary cntraindicatin addressing sterid dses TRANS Mechanical Circulatry Assist Devices (Ventricular Assist Devices, Percutaneus Ventricular Assist Devices and Artificial Hearts): This plicy addresses ventricular assist devices, percutaneus ventricular assist devices and artificial hearts. Title revised, previusly titled: Mechanical Circulatry Assist Devices (Ventricular Assist Devices and Artificial Hearts) Expanded scpe f plicy Added the use f percutaneus ventricular assist devices (e.g., TandemHeart System, Impella Recver LP 2.5 Percutaneus Cardiac Supprt System, and Impella Recver LP 5.0 Percutaneus Cardiac Supprt System) as investigatinal and nt medically necessary CG DRUG 13 Hepatitis B Interfern Antiviral Therapy: This guideline addresses the treatment f chrnic hepatitis B infectin with FDA apprved injectable agents Interfern alfa 2b and Peginterfern alfa 2a. Added cmpensated liver disease t medically necessary clinical indicatins as a required criteria Clarified nt medically necessary statement and added uncntrlled depressin t the list f cntraindicatins WellPint Medical Plicies and Clinical UM Guidelines are develped by ur Medical Plicy and Technlgy Assessment Cmmittee. The Cmmittee, which includes WellPint medical directrs and representatives frm practicing physician grups, meets quarterly t review current scientific data and clinical develpments. Medical Plicies and Clinical UM Guidelines are subject t the apprval f the Physician Relatins Cmmittee. All cverage written r administered by UniCare excludes frm cverage services r supplies that are investigatinal and/r nt medically necessary. A member s claim may nt be eligible fr payment if it was determined nt t meet medical necessity criteria set frth in WellPint s Medical Plicies. Review prcedures have been refined t facilitate claim investigatin. Cverage and administrative services are prvided by UniCare Life & Health Insurance Cmpany, a separately incrprated and capitalized subsidiary f WellPint, Inc. Registered mark f WellPint, Inc WellPint, Inc.
3 Yu can access the cmplete list f WellPint Medical Plicies and Clinical UM Guidelines frm > Prviders > WellPint Medical Plicies > adapted clinical UM guidelines. Attachment A The revised medical plicies listed belw will becme effective fr services rendered n r after January 15, Medical Plicy Number SURG Medical Plicy Title Endvascular/Endluminal Repair f Artic Aneurysms, Artiliac Disease, Artic Dissectin and Artic Transectin Medical Plicy Changes Updated system edits t match plicy psitin statement and cding sectin fr the fllwing cdes: Endvascular repair f descending thracic arta; invlving cverage f left subclavian artery rigin, initial endprsthesis plus descending thracic artic extensin(s), if required, t level f celiac artery rigin Endvascular repair f descending thracic arta; nt invlving cverage f left subclavian artery rigin, initial endprsthesis plus descending thracic artic extensin(s), if required, t level f celiac artery rigin Placement f prximal extensin prsthesis fr endvascular repair f descending thracic arta; initial extensin Placement f prximal extensin prsthesis fr endvascular repair f descending thracic arta; each additinal prximal extensin (list separately in additin t cde fr primary prcedure) Placement f distal extensin prsthesis(s) delayed after endvascular repair f descending thracic arta Open subclavian t cartid artery transpsitin perfrmed in cnjunctin with endvascular repair f descending thracic arta, by neck incisin, unilateral Bypass graft, with ther than vein, transcervical retrpharyngeal cartid cartid, perfrmed in cnjunctin with endvascular repair f descending thracic arta, by neck incisin Endvascular repair f infrarenal abdminal artic aneurysm r dissectin; using art artic tube prsthesis Endvascular repair f infrarenal abdminal artic aneurysm r dissectin; using mdular bifurcated prsthesis (1 dcking limb) Endvascular repair f infrarenal abdminal artic aneurysm r dissectin; using mdular bifurcated prsthesis (2 dcking limbs) Endvascular repair f infrarenal abdminal artic aneurysm r dissectin; using unibdy bifurcated prsthesis Endvascular repair f infrarenal abdminal artic aneurysm r dissectin; using art uniiliac r art unifemral prsthesis Cverage and administrative services are prvided by UniCare Life & Health Insurance Cmpany, a separately incrprated and capitalized subsidiary f WellPint, Inc. Registered mark f WellPint, Inc WellPint, Inc.
4 Medical Plicy Number SURG (cntinued) Medical Plicy Title Endvascular/Endluminal Repair f Artic Aneurysms, Artiliac Disease, Artic Dissectin and Artic Transectin (cntinued) Medical Plicy Changes Transcatheter placement f wireless physilgic sensr in aneurysmal sac during endvascular repair, including radilgical supervisin and interpretatin, instrument calibratin, and cllectin f pressure data (list separately in additin t cde fr primary prcedure) Endvascular placement f iliac artery cclusin device (list separately in additin t cde fr primary prcedure) Open femral artery expsure fr delivery f endvascular prsthesis, by grin incisin, unilateral Placement f femral femral prsthetic graft during endvascular artic aneurysm repair (list separately in additin t cde fr primary prcedure) Open iliac artery expsure fr delivery f endvascular prsthesis r iliac cclusin during endvascular therapy, by abdminal r retrperitneal incisin, unilateral Placement f prximal r distal extensin prsthesis fr endvascular repair f infrarenal abdminal artic r iliac aneurysm, false aneurysm, r dissectin; initial vessel Placement f prximal r distal extensin prsthesis fr endvascular repair f infrarenal abdminal artic r iliac aneurysm, false aneurysm, r dissectin; each additinal vessel (list separately in additin t cde fr primary prcedure) Endvascular repair f infrarenal abdminal artic aneurysm r dissectin, radilgical supervisin and interpretatin Placement f prximal r distal extensin prsthesis fr endvascular repair f infrarenal artic r iliac artery aneurysm, pseudaneurysm, r dissectin, radilgical supervisin and interpretatin Endvascular repair f descending thracic arta; invlving cverage f left subclavian artery rigin, initial endprsthesis plus descending thracic artic extensin(s), if required, t level f celiac artery rigin, radilgical supervisin and interpretatin Endvascular repair f descending thracic arta; nt invlving cverage f left subclavian artery rigin, initial endprsthesis plus descending thracic artic extensin(s), if required, t level f celiac artery rigin, radilgical supervisin and interpretatin Placement f prximal extensin prsthesis fr endvascular repair f descending thracic arta; radilgical supervisin and interpretatin Cverage and administrative services are prvided by UniCare Life & Health Insurance Cmpany, a separately incrprated and capitalized subsidiary f WellPint, Inc. Registered mark f WellPint, Inc WellPint, Inc.
5 SURG (cntinued) SURG Endvascular/Endluminal Repair f Artic Aneurysms, Artiliac Disease, Artic Dissectin and Artic Transectin (cntinued) Steretactic Radisurgery (SRS) and Steretactic Bdy Raditherapy (SBRT) Placement f distal extensin prsthesis(s) (delayed) after endvascular repair f descending thracic arta, as needed, t level f celiac rigin, radilgical supervisin and interpretatin Nninvasive physilgic study f implanted wireless pressure sensr in aneurysmal sac fllwing endvascular repair, cmplete study including recrding, analysis f pressure and wavefrm tracings, interpretatin and reprt Updated system edits t match plicy psitin statement and cding sectin fr the fllwing cdes: Radiatin treatment delivery, steretactic radisurgery (SRS), cmplete curse f treatment f cranial lesin(s) cnsisting f 1 sessin; multi surce Cbalt 60 based Radiatin treatment delivery, steretactic radisurgery (SRS), cmplete curse f treatment f cranial lesin(s) cnsisting f 1 sessin; linear acceleratr based Steretactic bdy radiatin therapy, treatment delivery, per fractin t 1 r mre lesins, including image guidance, entire curse nt t exceed 5 fractins G0173 Linear acceleratr based steretactic radisurgery, cmplete curse f therapy in ne sessin G0251 Linear acceleratr based steretactic radisurgery, delivery including cllimatr changes and custm plugging, fractinated treatment, all lesins, per sessin, maximum 5 sessins per curse f treatment G0339 Image guided rbtic linear acceleratr based steretactic radisurgery, cmplete curse f therapy in ne sessin, r first sessin f fractinated treatment G0340 Image guided rbtic linear acceleratr based steretactic radisurgery, delivery including cllimatr changes and custm plugging, fractinated treatment, all lesins, per sessin, secnd thrugh fifth sessins, maximum 5 sessins per curse f treatment Cverage and administrative services are prvided by UniCare Life & Health Insurance Cmpany, a separately incrprated and capitalized subsidiary f WellPint, Inc. Registered mark f WellPint, Inc WellPint, Inc.
Updates to Medical Policies and Clinical UM Guidelines
Updates t Medical Plicies and Clinical UM Guidelines Effective May 1, 2016 The majr new plicies and changes are summarized belw. Please refer t the specific plicy fr cding, language, and ratinale updates
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationSPECIALTY OF VASCULAR SURGERY Delineation of Clinical Privileges
SPECIALTY OF VASCULAR SURGERY Delineatin f Clinical Privileges Criteria fr granting privileges: Current certificatin by the American Bard f Surgery, r the American Ostepathic Bard f Surgery, and subspecialty
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationMedical Policy Title: Percutaneous Transluminal Endovascular Graft for Abdominal Aortic Aneurysm
ARBenefits Apprval: 10/19/2011 Effective Date: 01/01/2012 Revisin Date: Cde(s): Medical Plicy Title: Percutaneus Transluminal Endvascular Graft fr Abdminal Artic Aneurysm Dcument: ARB0147 34800 Endvascular
More informationTEXAS-MAC - PART B-TRAILBLAZER TABLE OF CONTENTS
TABLE OF CONTENTS CPT t LCD ID... 4 L26500- Autmatic Implantable Cardiac Defibrillatr (AICD) - 4C-58AB... 14 L26529- Cardiac Catheterizatin - 4C-50AB... 23 L26534- Transthracic Echcardigraphy (TTE) - 4C-52AB...
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationHIP REPLACEMENT SURGERY (ARTHROPLASTY)
Prtcl: ORT015 Effective Date: June 1, 2017 HIP REPLACEMENT SURGERY (ARTHROPLASTY) Table f Cntents Page COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE... 3 U.S.FOOD AND DRUG ADMINISTRATION
More information2017 CMS Web Interface
CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationREPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE
REPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN February 12, 2018 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap): XVIVO HIGHLIGHTS
More informationACRIN 6666 Screening Breast US Follow-up Assessment Form
Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related
More informationFolotyn (pralatrexate)
Fltyn (pralatrexate) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Original Effective Date: 10/01/2015 Current Effective Date: 01/01/2018TBD03/01/2017 POLICY A. INDICATIONS The indicatins
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More informationCUSTOMIZATION TO 22nd EDITION Original Date: March 26, 2018 CARE GUIDELINES
Issue Date: January 16, 2019 CUSTOMIZATION TO 22nd EDITION Original Date: March 26, 2018 CARE GUIDELINES NOTE: The five (5) prducts licensed include the fllwing: : Manage, review, and assess peple facing
More informationInternational Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1
Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-14-1-0444 TITLE: Culd HER2 Hetergeneity Open New Therapeutic Optins in Patients with HER2- Primary Breast Cancer? PRINCIPAL INVESTIGATOR: Gary Ulaner, MD, PhD CONTRACTING ORGANIZATION:
More informationContinuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP
Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationSolid Organ Transplant Benefits to Change for Texas Medicaid
Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a
More informationBenefits to Change for Diagnostic and Surgical/Reconstructive Breast Therapies and Corrective Procedures January 1, 2016
Benefits t Change fr Diagnstic and Surgical/Recnstructive Breast Therapies and Crrective Prcedures January 1, 2016 Infrmatin psted Nvember 13, 2015 Effective fr dates f service n r after January 1, 2016,
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationImmunisation and Disease Prevention Policy
Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries
More informationIndependent Charitable Patient Assistance Program (IPAP) Code of Ethics
Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin
More informationHospital Preparedness Checklist
Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been
More informationImplementation of G6PD testing and radical cure in P. vivax endemic countries: considerations
Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More information2017 CMS Web Interface
CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationNPCR CLINICAL EDIT CHECKS
NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t
More informationExtracranial Carotid Angioplasty/Stenting
Applies t all prducts administered r underwritten by Blue Crss and Blue Shield f Luisiana and its subsidiary, HMO Luisiana, Inc.(cllectively referred t as the Cmpany ), unless therwise prvided in the applicable
More informationMGPR Training Courses Guide
MGPR Training Curses Guide fiscal cde 92107050921 1. Descriptin The training prgram supprted by MGPR is prpsed by a grup f excellent mentrs/educatrs, accmplished in Pesticides Management and Analysis,
More informationErythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) Related Medical Guideline Off-Label Use of FDA-Approved Drugs and Biologicals
(Subcutaneus/Intravenus) Last Review Date: January 1, 2019 Number: MG.MM.PH.80 *NON-DIALYSIS* Medical Guideline Disclaimer C All rights reserved. The treating physician r primary care prvider must submit
More informationFee Schedule - Home Health Care- 2015
Fee Schedule - Hme Health Care- 2015 01/01/2015 1600 E Century Ave Ste 1 PO Bx 5585 Bismarck ND 58506-5585 www.wrkfrcesafety.cm Cpyright Ntice The five character cdes included in the Nrth Dakta Fee Schedule
More informationLEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST
OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED
More information1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU
More informationRituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage
Rituxan (rituximab) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Effective Date: 10/01/2015 POLICY A. INDICATIONS The indicatins belw including FDA-apprved indicatins and cmpendial uses
More informationA foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:
RADIOGRAPHY OF THE ANKLE AND FOOT (OTTAWA ANKLE RULES) Clinical Practice Guideline January 2007 This guideline has been adapted frm the Ottawa Ankle Rules develped by Dr. Ian Stiell et al. Dr. Stiell received
More informationNovel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.
Nvel methds and appraches fr sensing, evaluating, mdulating and regulating md and emtinal states. 2018 Jy Academic Grant Call fr Prpsals Intrductin The Annual Jy grant initiative aims t prmte and cntribute
More informationTHROUGH 1979, immunosuppressive
Five-Year Survival After Liver Transplantatin THROUGH 1979, immunsuppressive therapy fr liver transplantatin at ur center was with aathiprine (r cyclphsphamide) and sterids, t which antilymphcyte glublin
More informationAdded criteria requiring referral letters to mastectomy Medically Necessary statement.
NOTICE OF MATERIAL CHANGE TO CONTRACT January 1, 2019 RE: Medical Plicy and Clinical UM Guideline changes ntificatin letter Dear Prvider: Anthem Blue Crss and Blue Shield and ur subsidiary cmpany, HMO
More informationAdded criteria requiring referral letters to mastectomy Medically Necessary statement.
CHANGE NOTIFICATION TO MEDICAL POLICIES AND CLINICAL UM GUIDELINES January 1, 2019 RE: Medical Plicy and Clinical UM Guideline changes ntificatin letter Dear Prvider: Anthem Blue Crss and Blue Shield and
More informationCG-DRUG-64 FDA-Approved Biosimilar Products: This document provides clinical criteria for review of
March 30, 2017 [Prvider Name] [Cntact Title] [Address] [City], [State] [Zip] Dear Prvider: Anthem Blue Crss (Anthem) is pleased t prvide yu with ur updated Medical Plicies and Clinical UM Guidelines in
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More informationITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.
Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet
More information1100 Marie Mount Hall College Park, Maryland Tel: (301) Fax: (301)
UNIVERSITY SENATE 1100 Marie Munt Hall Cllege Park, Maryland 20742-7541 Tel: (301) 405-5805 Fax: (301) 405-5749 http://www.senate.umd.edu March 31, 2017 Jrdan Gdman Chair, University Senate 2208G Physical
More informationSUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY
EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY Sme 50% f cancers that affect wmen are lcated in the breast r in the genital rgans. Gynaeclgical
More informationUpdates to Medical Policies Effective October 1, 2017 and November 1, 2017
Updates t Medical Plicies Effective Octber 1, 2017 and Nvember 1, 2017 The majr new plicies and changes are summarized belw, and additinal updates are in Attachment A. Please refer t the specific plicy
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationGuidelines, Policies and Statements D19 Statement on Visceral Vascular Testing Using Ultrasound
Guidelines, Plicies and Statements D19 Statement n Visceral Vascular Testing Using Ultrasund Disclaimer and Cpyright The ASUM Standards f Practice Bard have made every effrt t ensure that this Guideline/Plicy/Statement
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationWidening of funding restrictions for rituximab and eltrombopag
20 February 2014 Widening f funding restrictins fr rituximab and eltrmbpag PHARMAC is pleased t annunce the apprval f prpsals t widen the restrictin n rituximab use in DHB hspitals and expand the funding
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationMylotarg (gemtuzumab ozogamicin) (Intravenous)
Myltarg (gemtuzumab zgamicin) (Intravenus) Last Review Date: 09/19/2017 Date f Origin: 09/19/2017 Dates Reviewed: 09/2017 Dcument Number: IC-0320 I. Length f Authrizatin Newly-Diagnsed AML De nv disease
More informationIndications and Limitations of Coverage and/or Medical back to top
Fr services perfrmed n r after 09/15/2009 Original Determinatin Ending Date Revisin Effective Date Revisin Ending Date Indicatins and Limitatins f Cverage and/r Medical Necessity Indicatins Medicare cverage
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationMedical Student Immunization Requirements
Medical Student Immunizatin Requirements The State f Illinis cde, Reference: (110 ILCS 20) Cllege Student Immunizatin Act, requires students t prvide prf f immunity: Measles (Rubela), Mumps, Rubella (German
More informationGuideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations
Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:
More informationINTERIM REPORT JANUARY SEPTEMBER 2017
INTERIM REPORT JANUARY SEPTEMBER 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN Octber 27, 2017 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap):
More informationMeasure Information Form
Release Ntes: Measure Infrmatin Frm Versin 2.0 **NQF-ENDORSED VOLUNTRY CONSENSUS STNDRDS FOR HOSPITL CRE** Measure Set: Heart Failure (HF) Set Measure ID#: Measure Infrmatin Frm Perfrmance Measure Name:
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More information2. How are screening and diagnostic mammograms different?
Mammgrams cmprises public dmain material frm the Natinal Cancer Institute at the Natinal Institutes f Health, an agency f the U.S. Department f Health and Human Services. Mammgrams Key Pints A mammgram
More informationUNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.
Initial privileges (initial appintment) Renewal f privileges (reappintment) Expansin f privileges (mdificatin) INSTRUCTIONS All new applicants must meet the fllwing requirements as apprved by the UNM SRMC
More informationPROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.
Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More information2016 CWA Political Action Fund Administrative Procedures Checklist
2016 CWA Plitical Actin Fund Administrative Prcedures Checklist 1. Dates f Prgram The 2016 CWA Plitical Actin Fund (federal plitical actin cmmittee- CWA-COPE PCC) Prgram will be cnducted n a calendar year
More informationOverview of ICD-10-CM & ICD-10-PCS
Overview f ICD-10-CM & ICD-10-PCS Presented By: Stacey Chevius, BA, AHI, CPC, CDIP AHIMA Apprved ICD-10-CM/PCS Trainer and Ambassadr May 2013 Why ICD-10? ICD-10 cde sets allw prviders t drill dwn int manifestatins
More informationBROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised:
Page 1 f 6 Subject: Range f Mtin Exercises Date Develped: 4/2010 PROTOCOL FOR: All trained staff PURPOSE: Range f Mtin (ROM) exercises are very imprtant if an individual has t stay in bed r in a wheelchair.
More informationPBTC-026: A Feasibility Study of SAHA Combined with Isotretinoin and Chemotherapy in Infants with Embryonal Tumors of the Central Nervous System
PBTC-026: A Feasibility Study f SAHA Cmbined with Istretinin and Chemtherapy in Infants with Embrynal Tumrs f the Central Nervus System PURPOSE: This clinical trial is studying the side effects f giving
More informationMaterials Dissecting pan, dissecting kit, safety glasses, lab apron, pig heart, & gloves
Heart Dissectin Intrductin Mammals have fur-chambered hearts and duble circulatin. The heart f a bird r mammal has tw atria and tw cmpletely separated ventricles. The dublelp circulatin is similar t amphibians
More informationPerjeta (pertuzumab) Document Number: IC I. Length of Authorization. Dosing Limits. Initial Approval Criteria
Perjeta (pertuzumab) Last Review Date: 11/21/2017 Date f Origin: 11/01/2012 Dcument Number: IC-0096 Dates Reviewed: 12/2012, 3/2013, 6/2013, 9/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014, 3/2015,
More informationFDA Dietary Supplement cgmp
FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes
More informationcerliponase alfa (Brineura )
cerlipnase alfa (Brineura ) Applies t all prducts administered r underwritten by Blue Crss and Blue Shield f Luisiana and its subsidiary, HMO Luisiana, Inc.(cllectively referred t as the Cmpany ), unless
More informationNQF 0075 Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
NQF 0075 Ischemic Vascular Disease (IVD): Cmplete Lipid Panel and LDL Cntrl Initial Patient Ppulatin: Numeratr(1): Numeratr(2): N Exclusin: Denminatr: D Exceptin: D Exclusin: Patients 18 years f age and
More informationRadiographic Procedures I Laboratory. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses
SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: 5. Subject: 6. Shrt Curse Title: 7. Effective Term:: RAD 61C Radigraphic Prcedures I Labratry Technlgy and Health Divisin
More information2017 CMS Web Interface
CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...
More informationNIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO
NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram
More informationRate Lock Policy. Contents
Rate Lck Plicy Cntents Rate Lcks... 2 Rate Lck Cnfirmatin... 2 Lck Term... 2 Pre-Lck... 2 Maximum Qualified Rate... 3 Extensins... 3 Cst t Extend... 3 Relcks... 4 Re-Negtiatin r Flat Dwn Plicy... 4 Prgram
More informationOntario s Referral and Listing Criteria for Adult Lung Transplantation
Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral
More informationCUSTOMIZATION TO 18th EDITION Original Date: February 24, 2014 CARE GUIDELINES
Issue Date: December 15, 2014 CUSTOMIZATION TO 18th EDITION Original Date: February 24, 2014 CARE GUIDELINES NOTE: This dcument prvides a high level summary f custmizatins and mdificatins made t MCG (frmerly
More informationUniversity College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service
University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,
More informationOriginal Policy Date
MP 7.01.113 Orthgnathic Surgery Medical Plicy Sectin Surgery Issue 12/2013 Original Plicy Date 12/2013 Last Review Status/Date Lcal Plicy created 12/2013 Return t Medical Plicy Index Disclaimer Our medical
More informationLower Extremity Amputation (LEA) Considerations / Issues
Lwer Extremity Amputatin (LEA) Cnsideratins / Issues Prviding Te Fillers can be an advantageus resurce fr yur patient and business but it als cmes with certain cnsideratins. Please review this list belw
More informationDRAFT Policy for the Management of Ear Wax
Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1
More informationThis standard operating procedure applies to stop smoking services provided by North 51.
Authr Name/Title Melanie McIlvar, Bid Develpment Manager Authr Signature Date: 4 th September 2017 Apprver Name/Title Jasn Shelley, Grup Directr f QA/RA Apprver Signature Date: 4 th September 2017 Issue
More informationP02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017
P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...
More informationLimitations and Exclusions (What is Not Covered)
Clrad Dental Family + Pediatric Plan Exclusins and Limitatins Limitatins and Exclusins (What is Nt Cvered) Excluded Services: Age 19 and lder Cvered Expenses d nt include expenses incurred fr: prcedures
More informationPROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS
PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS INTRODUCTION This ntice prvides an verview f the parental special educatin rights, smetimes called prcedural safeguards
More informationKadcyla (ado-trastuzumab emtansine) Document Number: IC-0092
Kadcyla (ad-trastuzumab emtansine) Dcument Number: IC-0092 Last Review Date: 2/6/2018 Date f Origin: 05/16/2013 Dates Reviewed: 7/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014, 5/2015, 8/2015,
More informationQP Energy Services LLC Hearing Conservation Program HSE Manual Section 7 Effective Date: 5/30/15 Revision #:
QP Energy Services LLC Hearing Cnservatin Prgram HSE Manual Sectin 7 Effective Date: 5/30/15 Revisin #: Prepared by: James Aregd Date: 5/30/15 Apprved by: James Aregd Date: 5/30/15 Page 1 f 8 Cntents Sectin
More informationC-SAS.2 Small Animal Soft Tissue Surgery (A)
C-SAS.2 Small Animal Sft Tissue Surgery (A) Credits: Prvider: 10 (100 hurs) Veterinary Pstgraduate Unit Schl f Veterinary Science RCVS Cntent Cvered The fllwing utlines the mdular cntent as set ut by the
More informationCUSTOMIZATION TO 19th EDITION Original Date: February 16, 2015 CARE GUIDELINES
Issue Date: December 14, 2015 CUSTOMIZATION TO 19th EDITION Original Date: February 16, 2015 CARE GUIDELINES NOTE: This dcument prvides a high level summary f custmizatins and mdificatins made t MCG (part
More informationAlcohol & Substance Misuse Policy. St Mary s CE Academy Trading Company. Date: Spring 2017 Date of Next Review: Summer 2018
St Mary s CE Academy Trading Cmpany Alchl & Substance Misuse Plicy Date: Spring 2017 Date f Next Review: Summer 2018 Signed by: Family Supprt Crdinatr Signed by: Grup Manager Alchl and Substance Misuse
More informationSpecifically, on page 12 of the current evicore draft, we find the statement:
Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit
More informationSignature Assignment. Course. ANTH 2346: General Anthropology. Assignment ID (to be assigned) Outcomes/Rubrics to be Assessed by the Assignment
Signature Assignment ANTH 2346: General Anthrplgy Outcmes/Rubrics t be Assessed by the Assignment Cmmunicatin Critical Thinking Empirical and Quantitative Reasning Scial Respnsibility Assignment Descriptin
More informationCorporate Governance Code for Funds: What Will it Mean?
Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,
More informationTRANSPLANTATION AND CLINICAL IMMUNOLOGY. Proceedings of the Twenty-Second International Course, Lyon, May 1990
-----.---.----~ Reprinted frm: TRANSPLANTATION AND CLINICAL IMMUNOLOGY VOLUME XXII Multiple Transplants Prceedings f the Twenty-Secnd Internatinal Curse, Lyn, 2-23 May 99 This publicatin was made pssible
More information